VaxInnate Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, Meets Phase 1 Seasonal Influenza Endpoints Top-Line Seroprotection Rates Exceed 90% in each of Four Vaccine Components; VAX2012Q to Proceed into Phase 2 Evaluation in 2015 VAX2012QCRANBURY, NJ,...
Kit Check Install Stories: Children’s Hospital of The King’s Daughters Kit Check Product Delivery Manager Scott Kinsky shares the story behind the installation of Kit Check at Children’s Hospital of The King’s Daughters in Norfolk, Virginia. November 12, 2014 Briefly...
Intarcia and Servier Sign Ex-U.S. Partnership for ITCA 650 in Diabetes; Intarcia Retains Independence & Full Control of the U.S. & Japan • Intarcia grants Servier exclusive rights to ITCA 650 in ex-U.S./Japan territories; Intarcia retains full control of ITCA...
TigerText Announces Integration with MobileIron to Deliver Secure Messaging Alliance brings TigerText secure enterprise messaging to MobileIron AppConnect ecosystem. Santa Monica, CA (November 12, 2014) – TigerText, the leader in secure real-time messaging for the...
Spiracur Secures $16M from GE Capital to Expand Sales and R&D Efforts SUNNYVALE, Calif., Nov. 12, 2014 – Spiracur Inc., developer of the only mechanically powered advanced wound care solution with the proven efficacy of Negative Pressure Wound Therapy (NPWT),...
Chimerix’s Brincidofovir Selected for Use in Ebola Clinical Trial in West Africa by International Consortium DURHAM, N.C., Nov. 13, 2014 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas...
Recent Comments